Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Panminerva Med ; 62(4): 244-251, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32432444

RESUMEN

BACKGROUND: To characterize variables that may predict the need for endoscopic intervention in inpatients admitted for several causes who during the hospitalization developed acute non-variceal upper gastrointestinal bleeding (NVUGIB). METHODS: A retrospective analysis of inpatients who underwent upper gastro-intestinal endoscopy for acute NVUGIB while hospitalized for other causes from 1 January 2016 to 1 December 2017, was performed. In the primary outcome analysis, patients (N.=14) who underwent endoscopic intervention (group A) were compared to those (N.=87) who did not need for endoscopic intervention (group B). Secondary outcome analysis included patients who had significant endoscopic findings compared to those who did not have them. RESULTS: Multivariate regression analysis showed that in the primary outcome analysis, two parameters were significant: the number of packed red blood cells (PRBC) units transfused (odds ratio [OR]: 1.5, P=0.01) and Rockall Score (RS) (OR: 1.4, P=0.06) with receiver operator characteristic (ROC) curve of 0.7844. In the secondary outcome analysis, only the use of proton pump inhibitor drugs at admission was associated with protective effect for the development of significant endoscopic findings (odds ratio [OR]: 0.42, P=0.05) with ROC curve of 0.7342. CONCLUSIONS: In hospitalized patients, in case of de novo NVUGIB, the number of PRBC units transfused and RS are predictive of significant endoscopic findings.


Asunto(s)
Endoscopía Gastrointestinal , Hemorragia Gastrointestinal/terapia , Hemostasis Endoscópica , Hospitalización , Anciano , Anciano de 80 o más Años , Endoscopía Gastrointestinal/efectos adversos , Endoscopía Gastrointestinal/mortalidad , Transfusión de Eritrocitos/efectos adversos , Femenino , Hemorragia Gastrointestinal/diagnóstico , Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/mortalidad , Hemostasis Endoscópica/efectos adversos , Hemostasis Endoscópica/mortalidad , Mortalidad Hospitalaria , Humanos , Pacientes Internos , Israel , Masculino , Persona de Mediana Edad , Factores Protectores , Inhibidores de la Bomba de Protones/uso terapéutico , Estudios Retrospectivos , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA